Difficult to Treat Cancer Cells can be Killed by Synthetic Lethality Nanoparticles

Difficult to Treat Cancer Cells can be Killed by Synthetic Lethality Nanoparticles

Researchers at the University of Iowa revealed on December 19, 2017, that they have developed a dual-action nanoparticles, which can selectively kill endometrial cancer cells also known as uterine serous carcinoma.

Chemotherapy is less effective as it only prevents cell division and do not inhibit existing cancerous cells. Cells with paused lifecycle are not prone to being eradicated by chemotherapy agents. The new nanoparticles approach overcomes this process. It stimulates the cancer cells to initiate mitosis and make them susceptible to chemotherapy that is suitably present.

The novel nanoparticle therapeutic approach combines paclitaxel, which is a common chemotherapy agent and nintedanib also known as BIBF 1120, which is a new cancer drug typically used to hinder angiogenesis. It was used to target cancer cells with a specific mutation in current treatments. The mutation that nintedanib screens is called Loss of Function p53 that prevents normal function of tumor cells and makes them less susceptible to chemotherapy.

“Basically, we are taking advantage of the tumor cells’ Achilles heel the Loss of Function mutation and then sweeping in and killing them with chemotherapy,” said Kareem Ebeid, a University of Iowa pharmacy student who was working on the study. “We call this a synthetically lethal situation because we are creating the right conditions for massive cell death.”

According to Nanoparticles Market report published by Coherent Market Insights, nanoparticle is currently a new area of research among many scientists as they can overcome the side effects of conventional cancer treatments using advance therapies involving nanoparticles. This approach was tested on endometrial cancer cells so far. It is expected to work on a variety of other cancers that show similar defensive properties.

Request a Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/216

You may be interested

Prosthetic Legs Market Is Supported By Innovative Devices And Their Improved Material
Healthcare
Healthcare

Prosthetic Legs Market Is Supported By Innovative Devices And Their Improved Material

Mohit Joshi - October 18, 2018

The Prosthetic Legs Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released Prosthetic Legs Market research report. The report has…

Urinalysis Market Growth Is To Be Deiven By Increasing Prevalence Of Kidney Diseases And Urinary Tract Infections
Healthcare
Healthcare

Urinalysis Market Growth Is To Be Deiven By Increasing Prevalence Of Kidney Diseases And Urinary Tract Infections

Mohit Joshi - October 18, 2018

The Urinalysis Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released Urinalysis Market research report. The report has been added…

Peripheral Vascular Devices Market – Growing geriatric population to drive the market growth
Healthcare
Healthcare

Peripheral Vascular Devices Market – Growing geriatric population to drive the market growth

Mohit Joshi - October 18, 2018

The Peripheral Vascular Devices Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released Peripheral Vascular Devices Market research report. The…

Most from this category